entertainment -WSS

entertainment

author：comprehensive 2025-09-03 11:51:17 - browse：91919

From 2017 to 2020, Stimwave implanted nearly 8,000 patients with nerve stimulators containing dummy pieces of plastic. Adobe

The Securities and Exchange Commission on Tuesday charged the former CEO of Stimwave, a company that sold devices containing dummy pieces of plastic, with defrauding investors out of $41 million.

Laura Perryman led Stimwave, which sold nerve stimulation devices to combat pain, from 2010 to 2019, when the fraud came to light. Under her leadership, Stimwave warped the design of the device to better align with insurance codes, resulting in unnecessary plastic components that allowed the company to sell their products for thousands of dollars more than they otherwise could. From 2017 to 2020, the company implanted nearly 8,000 patients with these devices.

STAT published new details about the Stimwave story in May, learning from former employees that Perryman broke into Stimwave’s Florida headquarters to steal back devices after her termination in 2019. The fraud laid bare the limits of the Food and Drug Administration’s device surveillance system, doctors’ ability to scrutinize device effectiveness, and how impossible it is for patients to get answers about the implants they receive.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Senate committee scrutinizes Medicare Advantage brokers

focus

WSS

Startup Neumora takes a novel depression drug to Phase 3

How dance can help nurses traumatized by Covid

Biden tests positive for Covid

Listen: Wegovy in the brain & pivotal Alzheimer's data

Custom gene therapy hints at new path for rare disease treatments

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

hotspot

entertainment

entertainment

ChatGPT in medicine: STAT answers readers' burning questions

STAT Summit: Biotech founders on deal

In Memoriam: Notable people who died in 2023

Biden tests positive for Covid

Hepatitis C has a cure — but many Americans still lack access to it

AI can’t replace a physician’s gut feeling

Malaria cases in Florida and Texas: Here’s what you need to know

Solve the antibiotic resistance crisis with preventive drugs

BioMarin wins approval for gene therapy to treat hemophilia A

How dance can help nurses traumatized by Covid

focus

STAT Readout Newsletter: Today's biggest biotech updates

HHS leader on health, climate change and biopharma emissions

At Orexo, a ‘turning point’ for everything but digital health

How climate

NIH confirmation hearing shows politicization of research

Pharmacists can make shortage drugs, but at what cost?

hotspot

focus

hotspot

knowledge